This event is now apart of the Clinical Diagnostics & Research Virtual Event Series.
Our 4th Annual Event in the Precision Medicine Virtual Event Series is now available On-Demand! The Precision Medicine planning committee carefully planned and selected speakers that best embodied the overall challenges, opportunities, and issues in the current landscape around precision medicine. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing.
Topics for this years event included:
Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 14 credits.
Use #LRprecisionmed to follow the conversation!
Systems Biologist, Laboratory of Systems Pharmacology, Harvard Medical School
Post Doctoral Research Scholar at University of California, San Francisco
Associate Professor of Neurology, SUNY Upstate Medical University
Associate Director of Clinical Genomics Research, Rady Children's Institute for Genomic Medicine
Global Product Manager, Oncology & Precision Diagnostics, QIAGEN
CEO & Founder, Comite Center for Precision Medicine
Director Scientific Collaboration , Department of Genetics, Washington University School of Medicine
Postdoctoral Research Associate, Department of Translational Genomics, Keck School of Medicine, University of Southern California
Assistant Professor of Computational Biomedicine in Medicine, Weill Cornell Medical College
Chief Operating Officer, Insight Genetics
Chief Scientific Officer, Pacific Biosciences
Research Assistant Professor of Urology, Northwestern University, Feinberg School of Medicine
Global Product Director of Oncology, QIAGEN Digital Insights
Senior Global Product Manager, QIAGEN
Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic
Senior Research Investigator, University of Pennsylvania
Senior Scientist, Computational Biology, 10X Genomics
Director, GPM Genetic Disease Informatics
As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new ...
See moreAs the scientific community races to solve this evolving global health crisis, Twist Bioscience is proud to carry on as an active partner for all of your research needs. Twist's unique silicon-based DNA writing platform allows for the rapid development of NGS panels for viral ...
See moreCHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHIs portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing ...
See moreInsight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical ...
See moreDavid I Smith received his B.S. in Mathematics and Molecular Biology from the University of Wisconsin in Madison. He then received his Ph.D. for the Department of Biochemistry also at the University of Wisconsin in Madison. After several postdoctoral positions he got his first ...
See moreDr. Sarah H. Elsea is an Associate Professor of Molecular and Human Genetics at Baylor College of Medicine and is Senior Division Director of Biochemical Genetics at Baylor Genetics. Dr. Elsea earned a B.S. in chemistry from Missouri State University and Ph.D. in biochemistry ...
See moreTatjana is an immunologist with more than two decades of experience working at biotech and pharma companies from start-ups to large global corporations ( Pfizer,Inc. being the latest), contributing significantly to team efforts and successes of more than thirty early and clinical ...
See moreKhyati Shah received her Ph.D. in Molecular Pharmacology from the University of the Pacific, Stockton, California. Her graduate research was completed in the lab of Jesika Faridi, Ph.D. Her work focused on the investigation of the mechanism of Akt induced tamoxifen resistance in ...
See more